Asthalin Inhaler
$ 50,00 – $ 215,00Price range: $ 50,00 through $ 215,00
Atacand
$ 42,00 – $ 383,00Price range: $ 42,00 through $ 383,00
Astralean
$ 49,00 – $ 670,00Price range: $ 49,00 through $ 670,00
Astralean is a potent bronchodilator designed to manage and treat chronic breathing disorders effectively. The active ingredient, Clenbuterol Hydrochloride, works by relaxing the smooth muscles in the airways to facilitate easier breathing. It is primarily utilized to alleviate symptoms associated with bronchial asthma and chronic obstructive pulmonary disease (COPD). By reducing airway resistance, this medication helps patients maintain better airflow and improves overall respiratory function. Each tablet is manufactured to high quality standards to ensure consistent relief from persistent respiratory congestion.
Active substance: Clenbuterol
SKU:
Astralean
Category: Weight Loss
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Astralean contains clenbuterol hydrochloride, a potent sympathomimetic amine belonging to the class of selective beta-2 adrenergic receptor agonists. This medication must only be used under direct medical supervision and in compliance with federal regulations, as clenbuterol is not approved by the Food and Drug Administration (FDA) for human prescription use in the United States.
While clenbuterol is utilized in certain international jurisdictions as a bronchodilator for respiratory disorders, its distribution and dispensing within the US are governed by applicable federal and state statutes. Any administration outside authorized clinical protocols carries substantial physiological risks, particularly regarding severe cardiovascular complications and metabolic imbalances.
Key Product Information
| Property | Details |
|---|---|
| Drug Name | Astralean |
| Active Ingredient | Clenbuterol hydrochloride |
| Therapeutic Class | Sympathomimetic beta-2 adrenergic agonist |
| Dosage Form | Oral tablet |
| Route of Administration | Oral |
| Primary Purpose | Bronchial smooth muscle relaxation (international indications) |
| US Regulatory Status | Dispensed in accordance with applicable federal and state regulations; unapproved for human use by the FDA. |
Main Uses and Regulatory Status
In countries where human use is licensed, clenbuterol hydrochloride is indicated primarily as a bronchodilator for managing reversible airway obstruction, such as chronic obstructive pulmonary disease (COPD) and bronchial asthma. By stimulating pulmonary beta-2 receptors, the compound relaxes bronchial smooth muscle tissue, reducing airway resistance and facilitating airflow.
In the United States, the FDA has not approved clenbuterol for human therapeutic use. The drug is strictly limited in US veterinary medicine to specific bronchodilator indications under veterinary prescription. Any off-label administration in humans–including unauthorized uses for weight loss, body re-composition, or performance enhancement–is non-FDA-approved, highly discouraged by public health authorities, and poses severe toxicological risks. Patients must rely exclusively on FDA-approved therapeutic alternatives prescribed by licensed healthcare providers.
How the Drug Works
Clenbuterol operates as a selective beta-2 adrenergic receptor agonist. Upon administration, it binds to beta-2 receptors located on the surface of bronchial smooth muscle cells. This binding activates the enzyme adenylate cyclase, triggering an increase in intracellular cyclic adenosine monophosphate (cAMP). Elevated cAMP levels activate protein kinase A, which inhibits myosin light-chain kinase phosphorylation, leading to significant relaxation of the pulmonary airway muscles.
Beyond its respiratory activity, clenbuterol exhibits secondary metabolic effects. Activation of beta-2 receptors in adipose and skeletal muscle tissue stimulates lipolysis and raises basal metabolic rate, leading to mild thermogenesis. However, at higher concentrations or prolonged exposure, clenbuterol loses its selectivity for beta-2 receptors and begins to stimulate cardiac beta-1 receptors. This cross-reactivity causes direct chronotropic and inotropic effects on cardiac tissue, increasing heart rate, myocardial oxygen demand, and the risk of cardiac arrhythmias.
What Happens in the Body
Following oral administration, clenbuterol hydrochloride is rapidly absorbed from the gastrointestinal tract, achieving high systemic bioavailability (estimated between 70% and 80%). Peak plasma concentrations are typically reached within 2 to 4 hours after ingestion. The compound binds moderately to plasma proteins and distributes widely throughout peripheral tissues, including pulmonary and cardiac structures.
The elimination half-life of clenbuterol in humans is notably prolonged, ranging approximately from 36 to 48 hours. This extensive terminal half-life contributes to persistent pharmacodynamic effects and increases the potential for cumulative toxicity during repeated administration. Metabolism occurs primarily in the liver through oxidative pathways. The drug and its metabolites are excreted predominantly through the kidneys via urinary elimination, requiring careful monitoring in individuals with impaired renal function.
Dosing Schedule and Administration Rules
Where legally authorized for human therapeutic use, dosing regimens are strictly individualized by a qualified clinical provider based on patient response, age, pulmonary function tests, and baseline cardiovascular metrics. Oral tablets are taken with water, typically divided into one or two daily doses to maintain stable therapeutic plasma levels.
Because clenbuterol possesses a narrow therapeutic index, dose titration must proceed with extreme caution under medical oversight. Unauthorized dose acceleration significantly increases the risk of severe acute toxicity, hyperadrenergic crisis, and acute myocardial ischemia. Patients must never alter dosages independently or exceed prescribers’ explicit instructions. If treatment is discontinued, a gradual dose taper under clinical direction may be required to prevent rebound bronchospasm or adrenergic receptor hypersensitivity.
What to Expect When Starting Treatment
During the initial phase of administration, patients frequently experience heightened sympathetic nervous system activation. Early signs commonly include peripheral hand tremors, mild restlessness, transient headaches, and a perceptible elevation in resting heart rate. These acute responses reflect central and systemic beta-adrenergic stimulation.
Routine physiological monitoring during initiation typically includes baseline and periodic electrocardiograms (ECGs), blood pressure measurements, and serum electrolyte panels. Most acute nervous system sensations peak within the first several days of administration, but persistent or accelerating cardiovascular signs require immediate clinical re-evaluation.
What to Avoid While Taking It
To reduce the likelihood of severe adverse events, individuals must avoid concomitant consumption of central nervous system or cardiovascular stimulants. Co-administration with caffeine, energy drinks, dietary weight-loss supplements, or over-the-counter sympathomimetic decongestants (such as pseudoephedrine or phenylephrine) can cause additive strain on the heart, leading to dangerous blood pressure spikes or ventricular dysrhythmias.
Alcohol consumption should be strictly avoided. Ethanol can amplify central nervous system irritability, obscure early signs of toxicity, and worsen cardiovascular instability associated with adrenergic stimulation. Furthermore, strenuous physical exertion in hot environments while under the influence of sympathomimetics heightens the risk of severe hyperthermia, rhabdomyolysis, and acute kidney injury.
Compatibility With Other Medicines
Clenbuterol exhibits critical drug interactions across several major pharmacological classes. Combining clenbuterol with beta-adrenergic blockers (such as propranolol, atenolol, or metoprolol) results in mutual pharmacological antagonism, negating therapeutic bronchodilation and potentially triggering severe, refractory bronchospasm.
Simultaneous use with other sympathomimetic agents, monoamine oxidase inhibitors (MAOIs), or tricyclic antidepressants drastically heightens cardiovascular risk, predisposing patients to hypertensive crisis, severe tachycardia, and cardiac ischemia. Concomitant administration with non-potassium-sparing diuretics (e.g., furosemide, hydrochlorothiazide) or systemic corticosteroids amplifies the risk of severe hypokalemia (dangerously low serum potassium levels), which can precipitate life-threatening cardiac arrhythmias.
Adverse Reactions
Adverse reactions associated with clenbuterol stem primarily from excessive or prolonged stimulation of the sympathetic nervous system. The severity of side effects depends heavily on dosage, systemic clearance, and individual cardiovascular susceptibility.
- Central Nervous System: Fine muscular tremors (particularly in the hands), anxiety, nervousness, agitation, insomnia, dizziness, and tension headaches.
- Cardiovascular System: Tachycardia, palpitations, elevated systolic blood pressure, cardiac chest pain, ventricular extrasystoles, and myocardial ischemia.
- Metabolic & Electrolyte Disturbances: Hypokalemia, transient hyperglycemia, elevated serum lactate, and muscle cramps related to electrolyte shifts.
- Gastrointestinal System: Nausea, dry mouth, gastric distress, and vomiting.
Important Precautions
Warning: Clenbuterol carries significant health risks, especially in patients with pre-existing cardiovascular conditions. Absolute caution and risk assessment are required prior to considering sympathomimetic therapy.
The drug is strongly contraindicated in individuals with severe ischemic heart disease, hypertrophic obstructive cardiomyopathy, acute myocardial infarction, severe tachyarrhythmias, hyperthyroidism, or pheochromocytoma. Patients with hypertension, diabetes mellitus, or underlying seizure disorders face elevated risks of severe decompensation.
Special populations require heightened vigilance:
- Pregnancy: Clenbuterol inhibits uterine contractions (tocolytic effect) and may impair fetal cardiac regulation. Use during pregnancy is generally avoided.
- Breastfeeding: It is unknown whether clenbuterol distributes into human breast milk. Due to potential toxicity in infants, nursing is not recommended.
- Pediatric & Elderly Populations: Children and elderly patients exhibit increased sensitivity to sympathomimetic toxicity, severe hypokalemia, and cardiac dysrhythmias.
Red Flags Requiring Emergency Care
Certain adverse events signal life-threatening complications that demand immediate emergency medical intervention. If any of the symptoms listed below occur, emergency medical services must be contacted immediately.
| Emergency Symptom | Clinical Risk / Underlying Condition |
|---|---|
| Severe chest pain or pressure | Myocardial ischemia or acute coronary syndrome |
| Rapid, irregular, or pounding heartbeat | Ventricular tachycardia or severe arrhythmia |
| Severe shortness of breath / sudden wheezing | Acute respiratory distress or paradoxical bronchospasm |
| Profound dizziness, confusion, or fainting (syncope) | Severe hypotension, reduced cerebral perfusion, or cardiac event |
| Extreme muscle weakness or acute paralysis | Severe hypokalemia altering muscular membrane potentials |
What’s Said vs. What’s True
Myth: “Clenbuterol is a safe, non-steroidal alternative for body building and fat loss.”
Fact: Clenbuterol is not an anabolic steroid; it is a potent sympathomimetic stimulant. Its off-label use for physique alteration carries severe risks of cardiac cell necrosis, pathological cardiac hypertrophy, and sudden cardiac death.
Myth: “Because it selectively targets beta-2 receptors, clenbuterol does not affect the heart.”
Fact: Beta-2 receptor selectivity is dose-dependent. At elevated plasma concentrations, selectivity is lost, leading to intense cardiac beta-1 stimulation, dangerous tachycardia, and ischemic cardiac stress.
Frequently Asked Questions
What should I do if a dose is accidentally missed?
If a prescribed dose is missed under an authorized therapeutic protocol, take it as soon as remembered, provided the next scheduled dose is not imminent. If it is almost time for the next dose, skip the missed dose and resume the standard schedule. Never double the dose to make up for a missed tablet, as doubling significantly increases the risk of acute adrenergic toxicity.
How does clenbuterol affect serum potassium levels?
Clenbuterol stimulates cellular membrane sodium-potassium ATPase pumps via beta-2 receptor activation, causing a shift of potassium ions from extracellular fluid into intracellular compartments. This process can lead to significant hypokalemia, manifested by muscle cramps, general weakness, severe cardiac dysrhythmias, and potential neuromuscular impairment.
Is it safe to drive or operate machinery while taking this medication?
No. Clenbuterol frequently causes fine muscle tremors, acute anxiety, dizziness, and cardiovascular agitation. These adverse effects can impair motor coordination, reaction times, and mental concentration. Individuals should refrain from driving, operating heavy machinery, or engaging in hazardous tasks until their individual physiological response to the medication is thoroughly established.
Why is clenbuterol not approved for human use by the FDA in the United States?
The US Food and Drug Administration (FDA) has not approved clenbuterol for human therapeutic use due to concerns over its long half-life, narrow therapeutic window, and substantial risk of cardiovascular toxicity relative to safer, shorter-acting FDA-approved beta-2 agonists (such as albuterol or levalbuterol).
Can clenbuterol be combined with prescription bronchodilators?
Combining clenbuterol with other short-acting or long-acting beta-agonist bronchodilators is hazardous. Concomitant administration leads to overstimulation of beta-adrenergic receptors, dramatically elevating the incidence of severe heart rate spikes, malignant arrhythmias, blood pressure instability, and acute metabolic disturbances.
Regulatory Notice and Disclaimer
In accordance with FDA guidelines and US federal regulations, clenbuterol hydrochloride is not approved for human consumption in the United States. Off-label or unauthorized administration carries significant health hazards.
This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.
Additional information
| Dosage |
40mcg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Hoodia
$ 80,00 – $ 294,00Price range: $ 80,00 through $ 294,00
Active substance: oxypregnane steroidal glycoside
More Details
This product has multiple variants. The options may be chosen on the product page
Karela
$ 63,00 – $ 79,00Price range: $ 63,00 through $ 79,00
Active substance: Normalized Karela Concentrate (Momordica charantia)
More Details
This product has multiple variants. The options may be chosen on the product page
Shuddha Guggulu
$ 49,00 – $ 292,00Price range: $ 49,00 through $ 292,00
Active substance: Shuddha Guggulu
More Details
This product has multiple variants. The options may be chosen on the product page
Slimonil
$ 53,00 – $ 76,00Price range: $ 53,00 through $ 76,00
More Details
This product has multiple variants. The options may be chosen on the product page
Trim Z
$ 50,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Victoza
$ 450,00 – $ 850,00Price range: $ 450,00 through $ 850,00
Active substance: Liraglutide
More Details
This product has multiple variants. The options may be chosen on the product page
Vyfat
$ 40,00 – $ 105,00Price range: $ 40,00 through $ 105,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
Xenical
$ 45,00 – $ 400,00Price range: $ 45,00 through $ 400,00
Active substance: Orlistat
More Details
This product has multiple variants. The options may be chosen on the product page
